Shuren Ma

2.3k total citations
62 papers, 1.4k citations indexed

About

Shuren Ma is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, Shuren Ma has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 12 papers in Genetics. Recurrent topics in Shuren Ma's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Connective tissue disorders research (12 papers) and Neonatal Respiratory Health Research (11 papers). Shuren Ma is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Connective tissue disorders research (12 papers) and Neonatal Respiratory Health Research (11 papers). Shuren Ma collaborates with scholars based in United States, China and United Kingdom. Shuren Ma's co-authors include Gerard M. Turino, Yong Y. Lin, Jerome Cantor, Seymour Lieberman, Maurizio Luisetti, Joseph M. Cerreta, Jiangtao He, Gerard Turino, Zhao‐Shen Li and Yu Bai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shuren Ma

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuren Ma United States 22 697 317 289 271 238 62 1.4k
Malika Balduyck France 22 412 0.6× 416 1.3× 234 0.8× 96 0.4× 79 0.3× 68 1.3k
Achyut Bhattacharyya United States 13 506 0.7× 140 0.4× 378 1.3× 748 2.8× 114 0.5× 16 1.5k
Patrice Berthézène France 17 312 0.4× 558 1.8× 671 2.3× 290 1.1× 112 0.5× 22 1.7k
John R. Stroehlein United States 21 328 0.5× 346 1.1× 461 1.6× 395 1.5× 75 0.3× 60 1.3k
Ignacio Romero Spain 23 302 0.4× 476 1.5× 420 1.5× 279 1.0× 110 0.5× 98 1.5k
Yinying Lu China 24 302 0.4× 620 2.0× 432 1.5× 284 1.0× 84 0.4× 99 1.8k
Kung‐Kai Kuo Taiwan 22 294 0.4× 508 1.6× 317 1.1× 423 1.6× 48 0.2× 70 1.5k
Noboru Hara Japan 20 615 0.9× 467 1.5× 244 0.8× 302 1.1× 59 0.2× 106 1.4k
Jie Huang China 23 220 0.3× 577 1.8× 340 1.2× 190 0.7× 55 0.2× 97 1.4k
Fernand M.M. Lai Hong Kong 15 180 0.3× 650 2.1× 134 0.5× 437 1.6× 172 0.7× 30 1.6k

Countries citing papers authored by Shuren Ma

Since Specialization
Citations

This map shows the geographic impact of Shuren Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuren Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuren Ma more than expected).

Fields of papers citing papers by Shuren Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuren Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuren Ma. The network helps show where Shuren Ma may publish in the future.

Co-authorship network of co-authors of Shuren Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shuren Ma. A scholar is included among the top collaborators of Shuren Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuren Ma. Shuren Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blarigan, Erin L. Van, Xingjian Liu, Shuren Ma, et al.. (2022). Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 9(3). 377–393. 3 indexed citations
2.
Cantor, Jerome, Shuren Ma, Xingjian Liu, et al.. (2021). A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy. Respiratory Medicine. 182. 106402–106402. 13 indexed citations
3.
Ma, Shuren, et al.. (2020). The Proinflammatory Activity of Structurally Altered Elastic Fibers. American Journal of Respiratory Cell and Molecular Biology. 63(5). 699–706. 16 indexed citations
4.
Campos, Michael, Patrick Geraghty, Gregory E. Holt, et al.. (2019). The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 200(3). 318–326. 59 indexed citations
5.
Du, Xin, Yang Zheng, Ping Yang, et al.. (2019). YINGLONG: A Multicenter, Prospective, Non-Interventional Study Evaluating the Safety and Tolerability of Ticagrelor in Chinese Patients with Acute Coronary Syndrome. Advances in Therapy. 36(7). 1595–1605. 1 indexed citations
6.
Ma, Shuren, Patrick Geraghty, Abdoulaye Dabo, et al.. (2019). Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation. ERJ Open Research. 5(2). 250–2018. 5 indexed citations
7.
8.
Zhang, Yingchun, et al.. (2014). Clinical features of and therapeutic ERCP for 1 158 patients with pancreatobiUary diseases. Zhonghua xiaohua neijing zazhi. 31(3). 143–147.
9.
Liu, Guoping, et al.. (2012). Therapeutic transjejunal endoscopy for the treatment of biliary complications after choledochojejunostomy. Experimental and Therapeutic Medicine. 5(2). 499–502. 2 indexed citations
10.
Turino, Gerard M., Shuren Ma, Yong Y. Lin, Jerome Cantor, & Maurizio Luisetti. (2011). Matrix Elastin: A Promising Biomarker for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 184(6). 637–641. 45 indexed citations
11.
Ma, Shuren, Gerard M. Turino, & Yong Y. Lin. (2011). Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC–MS/MS as biomarkers for elastin degradation. Journal of Chromatography B. 879(21). 1893–1898. 65 indexed citations
12.
13.
Grosu, Horiana B., et al.. (2010). Detection of Elastin Degradation Products in the Blood and Urine of Patients With Pulmonary Arterial Hypertension. CHEST Journal. 138(4). 891A–891A. 1 indexed citations
14.
Ma, Shuren, et al.. (2009). The effect of tiotropium therapy on markers of elastin degradation in COPD. Respiratory Research. 10(1). 12–12. 29 indexed citations
15.
Luisetti, Maurizio, Shuren Ma, Paolo Iadarola, et al.. (2008). Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. European Respiratory Journal. 32(5). 1146–1157. 105 indexed citations
16.
Kulkarni, Girish S., Priya Nadkarni, Joseph M. Cerreta, Shuren Ma, & Jerome Cantor. (2007). SHORT-TERM CIGARETTE SMOKE EXPOSURE POTENTIATES ENDOTOXIN-INDUCED PULMONARY INFLAMMATION. Experimental Lung Research. 33(1). 1–13. 13 indexed citations
17.
Cantor, Jerome, et al.. (2006). Synergistic Effect of Hydrogen Peroxide and Elastase on Elastic Fiber Injury In Vitro. Experimental Biology and Medicine. 231(1). 107–111. 11 indexed citations
18.
Lieberman, Seymour, Shuren Ma, & Yan He. (2005). New assumptions about oxidative processes involved in steroid hormone biosynthesis: Is the role of cytochrome P-450-activated dioxygen limited to hydroxylation reactions or are dioxygen insertion reactions also possible?. The Journal of Steroid Biochemistry and Molecular Biology. 94(5). 405–420. 6 indexed citations
19.
Nadkarni, Priya, Girish S. Kulkarni, Joseph M. Cerreta, Shuren Ma, & Jerome Cantor. (2005). DICHOTOMOUS EFFECT OF AEROSOLIZED HYALURONAN IN A HAMSTER MODEL OF ENDOTOXIN-INDUCED LUNG INJURY. Experimental Lung Research. 31(9-10). 807–818. 13 indexed citations
20.
Ma, Shuren. (1999). Studies of Drug Releasing Properties on Gels Containing Tanshinone. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malika Balduyck Breakdown of academic impact, for papers by Achyut Bhattacharyya Breakdown of academic impact, for papers by Patrice Berthézène Breakdown of academic impact, for papers by John R. Stroehlein Breakdown of academic impact, for papers by Ignacio Romero Breakdown of academic impact, for papers by Yinying Lu Breakdown of academic impact, for papers by Kung‐Kai Kuo Breakdown of academic impact, for papers by Noboru Hara Breakdown of academic impact, for papers by Jie Huang Breakdown of academic impact, for papers by Fernand M.M. Lai
Rankless by CCL
2026